Subscribe To
MVRBF / Medivir to present at the Redeye Fight Cancer Day
STOCKHOLM , Jan. 16, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will participate at the Redeye Fight Cancer Day on January 19, 2023. CEO Jens Lindberg will present the company and its plan for the ongoing clinical study with fostroxacitabine bralpamide (fostrox) at 13.35 CET.
Read More
Posted: Jan 16 2023, 03:41
Author Name: PRNewsWire
Views: 110791
MVRBF News
By PRNewsWire
January 16, 2023
Medivir to present at the Redeye Fight Cancer Day
STOCKHOLM , Jan. 16, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments f more_horizontal